Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BIOS Insider Trading

BIOS | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at BIOS provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2017-11-14 00:00 2017-11-09 Deitsch Stephen Officer - Chief Financial Officer BUY $2.03 10,000 $20,300 10,000 +100.0%
2017-11-13 23:58 2017-11-09 GREENLEAF DANIEL E Officer - Chief Executive Officer BUY $2.03 15,000 $30,495 31,000 +93.8%
2017-09-19 22:59 2017-09-15 Bronfein Michael G Director SELL $2.69 27,000 $72,733 129,669 -17.2%
2017-09-08 02:09 2017-09-05 Coliseum Capital Management, LLC Director, 10% owner SELL $2.93 2,846,941 $8,351,501 1,888,991 -60.1%
2017-08-18 02:45 2017-08-15 Coliseum Capital Management, LLC Director, 10% owner SELL $3.08 886,478 $2,732,302 4,735,932 -15.8%
2016-11-14 19:27 2016-11-11 Kreger Jeffrey M Officer - Chief Financial Officer BUY $1.32 10,000 $13,200 22,628 +79.2%
2016-11-14 17:06 2016-11-10 GREENLEAF DANIEL E Officer - Chief Executive Officer BUY $1.30 16,000 $20,784 16,000 +100.0%
2016-11-14 17:04 2016-11-10 Pate R Carter Director BUY $1.30 20,000 $26,000 84,000 +31.3%
2016-06-22 21:51 2016-06-22 Coliseum Capital Management, LLC Director, 10% owner BUY $2.00 4,200,000 $8,400,000 5,622,410 +295.3%
2016-06-21 03:37 2016-06-17 Bronfein Michael G Director BUY $2.50 80,000 $199,728 80,000 +100.0%
2016-06-21 00:10 2016-06-17 GOLDSTEIN MICHAEL Director BUY $2.49 25,000 $62,195 25,000 +100.0%
2016-06-20 23:58 2016-06-17 Pate R Carter Director BUY $2.50 25,000 $62,408 30,000 +500.0%
2016-06-20 23:57 2016-06-17 GOLDING DAVID W Director BUY $2.48 12,500 $30,978 42,500 +41.7%
2015-08-27 02:03 2015-08-24 Coliseum Capital Management, LLC Director, 10% owner BUY $1.88 789,503 $1,484,266 1,422,410 +124.7%
2015-08-27 01:56 2015-08-21 Coliseum Capital Management, LLC Director, 10% owner BUY $1.82 397,900 $724,178 632,907 +169.3%
2015-08-25 03:07 2015-08-20 Coliseum Capital Management, LLC Director, 10% owner BUY $1.81 632,907 $1,142,460 632,907 +100.0%
2015-08-19 18:56 2015-08-18 GOLDING DAVID W Director BUY $1.54 20,000 $30,820 30,000 +200.0%
2015-05-21 23:05 2015-05-19 GOLDING DAVID W Director BUY $4.02 10,000 $40,159 10,000 +100.0%
2015-03-17 22:30 2015-03-16 SMITH RICHARD M Director, Officer - President and CEO BUY $4.27 5,000 $21,350 135,000 +3.8%
2015-03-13 21:17 2015-03-12 JORDEN YON Director BUY $3.47 5,000 $17,350 20,000 +33.3%
2013-09-04 00:15 2013-08-29 colucci daniel Officer - Vice President, PBM Services OPT+S $12.40 18,500 $229,359 2,580 0.0%
2013-08-30 23:58 2013-08-28 HUBERS DAVID R Director OPT+S $12.23 11,200 $136,976 71,360 0.0%
2013-08-29 23:41 2013-08-28 Bogusz Patricia Officer - Vice President, Finance OPT+S $11.94 39,687 $473,863 3,028 0.0%
2013-08-20 23:40 2013-08-19 Kohlberg Management V, LLC 10% owner, Other SELL $13.00 6,895,873 $89,646,349 1,788,542 -79.4%
2013-07-24 00:59 2013-07-19 HOLUBIAK MYRON Z Director OPT+S $16.34 31,200 $509,730 30,000 0.0%
2013-04-27 00:29 2013-04-24 Kohlberg Management V, LLC 10% owner, Other SELL $11.40 3,968,750 $45,243,750 8,684,415 -31.4%
2012-12-18 20:17 2012-12-14 HOLUBIAK MYRON Z Director SELL $10.82 10,000 $108,232 20,000 -33.3%
2012-11-15 19:37 2012-11-13 SAMUELS STUART A Director OPT+S $9.66 11,200 $108,228 46,500 0.0%
2012-09-10 21:51 2012-09-06 HOLUBIAK MYRON Z Director OPT+S $8.51 9,600 $81,669 30,000 0.0%
2012-09-06 01:32 2012-08-31 HOLUBIAK MYRON Z Director OPT+S $8.50 6,800 $57,833 30,000 0.0%
2012-05-17 21:59 2012-05-14 Bogusz Patricia Officer - Vice President, Finance OPT+S $7.52 14,000 $105,280 3,028 0.0%
2012-04-23 23:15 2012-04-17 FRIEDMAN RICHARD H Other OPT+S $7.01 34,300 $240,546 380,179 0.0%
2012-04-17 22:12 2012-04-12 FRIEDMAN RICHARD H Director OPT+S $7.00 8,700 $60,939 149,579 0.0%
2012-04-09 18:43 2012-04-03 FRIEDMAN RICHARD H Director OPT+S $7.02 114,600 $803,930 154,279 0.0%
2012-04-03 23:31 2012-04-02 FRIEDMAN RICHARD H Director OPT+S $7.00 36,312 $254,199 154,279 0.0%
2012-03-22 01:35 2012-03-19 FRIEDMAN RICHARD H Director SELL $6.77 100,000 $676,760 154,279 -39.3%
2012-03-19 21:28 2012-03-09 FRIEDMAN RICHARD H Director OPT+S $7.03 105,167 $739,555 254,279 0.0%
2012-03-06 19:16 2012-03-01 FRIEDMAN RICHARD H Director OPT+S $6.40 20,000 $128,034 282,779 0.0%
2012-02-07 00:24 2012-02-02 FRIEDMAN RICHARD H Director OPT+S $6.34 40,000 $253,600 282,779 0.0%
2011-12-21 22:15 2011-12-16 FRIEDMAN RICHARD H Director SELL $5.51 4,674 $25,760 282,779 -1.6%
2011-12-16 23:27 2011-12-15 HOLUBIAK MYRON Z Director SELL $5.43 8,500 $46,141 20,000 -29.8%
2011-12-08 04:22 2011-12-05 FRIEDMAN RICHARD H Director SELL $6.08 30,200 $183,547 287,453 -9.5%
2011-12-05 23:38 2011-12-01 FRIEDMAN RICHARD H Director OPT+S $6.08 20,000 $121,538 317,653 0.0%
2011-11-22 01:50 2011-11-18 SAMUELS STUART A Director OPT+S $5.49 11,200 $61,488 36,500 0.0%
2011-10-25 01:25 2011-10-20 POSNER BARRY A Other SELL $6.11 4,000 $24,424 30,410 -11.6%
2011-10-18 21:58 2011-10-14 FRIEDMAN RICHARD H Director SELL $7.00 4,000 $28,000 317,653 -1.2%
2011-10-18 01:14 2011-10-13 POSNER BARRY A Other SELL $7.00 200 $1,400 34,410 -0.6%
2011-10-14 20:32 2011-10-12 FRIEDMAN RICHARD H Director SELL $7.00 40,488 $283,594 321,653 -11.2%
2011-10-13 00:57 2011-10-07 POSNER BARRY A Other SELL $6.97 5,600 $39,016 34,610 -13.9%
2011-10-07 21:53 2011-10-06 POSNER BARRY A Other SELL $6.75 925 $6,244 40,210 -2.2%
SHOW ENTRIES
1-50 OF 112

How to Interpret $BIOS Trades

Not every insider transaction in BIOS is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BIOS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BIOS

Insider activity data for BIOS is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BIOS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.